Tardive Dyskinesia - StatPearls - NCBI Bookshelf

Tardive dyskinesia (TD) is a syndrome that encompasses a constellation of iatrogenic movement disorders caused by the antagonism of dopamine receptors. The movement disorders include akathisia, dystonia, buccolingual stereotypy, chorea, tics, and other abnormal involuntary movements. Most often, these dyskinetic disorders precipitate following chronic antipsychotic administration; however, several other medications are also associated with tardive dyskinesia. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM V) defines tardive dyskinesia as a medication-induced movement disorder that persists despite discontinuation or change of the medications. As per DSM-V, to confirm a diagnosis of tardive dyskinesia, symptoms must persist for at least one month after discontinuation of the medication.[1][2][3]

Tardive Dyskinesia - StatPearls - NCBI Bookshelf The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Bookshelf Search database Books All Databases Assembly Biocollections BioProject BioSample Books ClinVar Conserved Domains dbGaP dbVar Gene Genom

related reading

• The Degradation Drug - The American Scholartheamericanscholar.org
• Parkinson Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• The Degradation Drug - The American Scholartheamericanscholar.org
• Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis - Parkinson’s Disease - NCBI Bookshelfncbi.nlm.nih.gov
• Lewy Body Dementia - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• Myotonic Dystrophy: What It Is, Symptoms, Types & Treatmentmy.clevelandclinic.org
• Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research | Metabolic Brain Disease | Springer Nature Linklink.springer.com
• Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D2- muscarinic acetylcholine M1 receptor heteromer - PMCncbi.nlm.nih.gov
• Some Predictions About the Future of “Withdrawal Studies”psychiatrymargins.com
• Parkinson’s Disease and Parkinsonism: Neuropathology - PMCpmc.ncbi.nlm.nih.gov
• Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study - PMCpmc.ncbi.nlm.nih.gov
• ALS - Wikipediaen.wikipedia.org